Metabolic Disease News and Research

RSS

Can pregnancy leave a lasting mark on biological aging?

A review examines how pregnancy spacing affects maternal aging, proposing that insufficient recovery may lead to cumulative biological aging and health risks.

3 Nov 2026

Can broccoli sprouts help with insulin resistance? New review offers clues

A review published in the British Journal of Nutrition examines how carotenoids and bioactive compounds in Brassicaceae microgreens may influence obesity, insulin resistance, and type 2 diabetes through metabolic and inflammatory pathways. Small human trials involving broccoli sprouts have reported improvements in selected metabolic markers, but larger, longer-term studies are needed to establish their clinical benefits.

29 Oct 2026

Men with lower testosterone at 31 reported good health 15 years later

Researchers analyzed testosterone concentrations measured at age 31 in 2,691 Finnish men and assessed self-reported health, medical conditions, and quality of life at age 46. Men across testosterone quartiles generally reported good health and excellent quality of life, while differences in metabolic and gastrointestinal conditions lost statistical significance after adjustment for waist circumference.

27 Oct 2026

New AI model detects hidden diseases in routine CT scans

When analyzed by a new artificial intelligence model developed at Penn Medicine, CT scans reveal much about a patient's health beyond the specific condition they were originally ordered for, according to a new study published in NPJ Digital Medicine.

20 Oct 2026

Miro1 protein linked to insulin resistance in type 2 diabetes

A protein called Miro1 found at elevated levels in the skeletal muscle of people with Type 2 diabetes may contribute to insulin resistance, potentially making it a target for future treatments that help the body regulate blood sugar, according to a study published today in Nature Communications.

19 Oct 2026

Study: First 90 days of antipsychotic treatment critical for metabolic changes

The first 90 days after starting antipsychotic treatment are crucial for changes in blood sugar and weight, finds a new study led by UCL researchers.

14 Oct 2026

Nutritionally similar meals might not affect your body the same way

Ultra-processed foods trigger distinct metabolic and brain responses, influencing insulin release and nutrient processing despite similar nutritional content.

8 Oct 2026

Dr. GPCR and Eurofins Discovery join forces to advance GPCR drug discovery

Dr. GPCR, the global knowledge hub for G protein-coupled receptor (GPCR) research and education, today announced a strategic partnership with Eurofins Discovery, the drug discovery services side of the same group behind the Eurofins DiscoverX products many in the community already know.

From Eurofins Discovery 5 Oct 2026

New project explores mitochondrial evolution across diverse life forms

A research consortium has generated the broadest look yet at the proteins that make up mitochondria, capturing the organelle's diversity across multiple branches on the tree of complex life.

1 Oct 2026

Kingston University joins major London partnership for health and social care research

Kingston University, London has joined a new London-wide partnership to deliver health and social care transformation through research.

1 Oct 2026

Novo Nordisk Foundation funds genomic research into metabolic diseases

The Novo Nordisk Foundation has committed $53 million to renew and expand the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease at the Broad Institute, led by managing director Kasper Lage.

30 Sep 2026

Laverock Therapeutics announces in vivo programs in oncology and genetic medicine

Laverock Therapeutics (‘Laverock’), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announces its in vivo programs spanning CAR-T and genetic medicine

From Laverock Therapeutics 30 Sep 2026

$5.7 million NIH grant supports research on why lean people develop insulin resistance

A Wayne State University research team was awarded a $5.7 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health focused on discovering the biological mechanisms that may help explain why some lean people develop insulin resistance while some people with obesity remain sensitive to insulin.

29 Sep 2026

Intestinal enzyme links microbial metabolism to MASH progression

Metabolic dysfunction-associated steatohepatitis (MASH) is often viewed through the lens of hepatic lipid accumulation, inflammation and fibrosis. A new study published in eGastroenterology shifts attention upstream, identifying intestinal neutral ceramidase as a gut-derived driver of MASH progression through its effects on microbial metabolism, epithelial signalling and intestinal barrier function.

29 Sep 2026

Gut bacteria signature may predict type 2 diabetes risk

Changes in the composition of bacteria in the gut could provide early warning of type 2 diabetes (T2D), new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) has found.

27 Sep 2026

A child's gut microbiome may offer early clues to type 1 diabetes risk

Researchers tracking 887 children at high genetic risk of type 1 diabetes identified three distinct patterns of gut microbiome maturation during early childhood. One pattern was associated with substantially higher risk of islet autoantibody seroconversion or type 1 diabetes, while host genetic background altered the risk associated with another pattern.

23 Sep 2026

Childhood trauma linked to risky health behaviors in late adolescence

Experiencing childhood trauma appears to increase a young person's likelihood of smoking, substance use and developing unhealthy eating habits by contributing to behavioral problems during adolescence, such as impulsivity and poor self-control.

22 Sep 2026

Siemens Healthineers and Novo join forces to advance care for people living with MASLD and MASH

Siemens Healthineers and Novo have announced a collaboration focused on advancing care for people living with metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH).

From Siemens Healthineers 22 Sep 2026

Study identifies brain mechanism behind pregnancy-related food cravings

Why do food cravings become so strong during pregnancy? Researchers at LSU's Pennington Biomedical Research Center, in collaboration with colleagues, have identified a brain mechanism that may help explain how pregnancy changes the motivation to seek certain highly palatable foods.

18 Sep 2026

Scientists discover metabolite fueling aggressive brain tumor growth

Virtually all high-grade, aggressive gliomas in adults accumulate massive amounts of a metabolite called guanidinoacetate (GAA) that overstimulates nearby neurons and promotes tumor growth, according to new research from scientists at Children’s Medical Center Research Institute at UT Southwestern (CRI) published in Cell.

18 Sep 2026